AmSurg Corp. Announces Sale of Common Stock by Affiliates of Hellman & Friedman LLC
November 10 2014 - 04:30PM
Business Wire
AmSurg Corp. (the “Company”) (NASDAQ: AMSG) today announced that
certain of its shareholders, consisting of affiliates of Hellman
& Friedman LLC (the “Selling Shareholders”), intend to offer
for sale in an underwritten secondary offering 4,509,213 shares of
the Company’s common stock pursuant to the Company’s shelf
registration statement filed with the Securities and Exchange
Commission (the “SEC”). The Selling Shareholders will receive all
of the proceeds from this offering. No shares are being sold by
management or the Company. The last reported sale price of the
Company’s common stock on November 10, 2014, was $51.84 per
share.
Goldman, Sachs & Co. will act as underwriter for the
offering.
The Company has filed a registration statement (including a
prospectus) with the SEC for the offering to which this
communication relates. Before you invest, you should read the
prospectus in that registration statement and other documents the
Company has filed with the SEC for more complete information about
the Company and this offering. You may obtain these documents for
free by visiting EDGAR on the SEC Web site at: www.sec.gov.
Alternatively, copies of the prospectus supplement and accompanying
prospectus relating to the offering, when available, may be
obtained from:
Goldman, Sachs & Co.Attn: Prospectus Department200 West
StreetNew York, NY 10282Telephone: (212) 902-1171Facsimile: (212)
902-9316E-mail: prospectus-ny@ny.email.gs.com
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy any securities nor will there be
any sale of these securities in any state or other jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or other jurisdiction.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the federal securities laws, including statements
that are based on current expectations, forecasts and assumptions
that involve risks and uncertainties that could cause actual
outcomes and results to differ materially. Forward-looking
statements relate to expectations, beliefs, projections, future
plans and strategies, anticipated events or trends and similar
expressions concerning matters that are not historical facts.
In some cases, you can identify forward-looking statements by
the use of forward-looking terminology such as “may,” “will,”
“should,” “expects,” “intends,” “plans,” “anticipates,” “believes,”
“estimates,” or “predicts,” or the negative of these words or
phrases or similar words or phrases, which are predictions of or
indicate future events or trends and which do not relate solely to
historical matters. While forward-looking statements reflect the
Company’s good faith beliefs, assumptions and expectations, they
are not guarantees of future performance. Furthermore, the Company
disclaims any obligation to publicly update or revise any
forward-looking statement to reflect changes in underlying
assumptions or factors, of new information, data or methods, future
events or other changes. Certain risks and uncertainties related to
the Company’s business are or will be described in greater detail
in the Company’s filings with the SEC. The information set forth
herein should be read in light of such risks.
About AmSurg Corp.
AmSurg Corp. operates an Ambulatory Services business that
acquires, develops and operates ambulatory surgery centers in
partnership with physician practice groups throughout the U.S.
AmSurg also operates a Physician Services business that provides
outsourced physician services in multiple specialties to hospitals,
ASCs and other healthcare facilities, primarily in the areas of
anesthesiology, children’s services, emergency medicine and
radiology. Through these businesses as of September 30, 2014,
AmSurg owns and operates 243 ASCs in 34 states and provides
physician services in 25 states, employing more than 2,600
physicians and other healthcare professionals.
AmSurg Corp.Claire M. Gulmi, 615-665-1283Executive Vice
President and Chief Financial Officer
Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amsurg Corp. (NASDAQ:AMSG)
Historical Stock Chart
From Mar 2023 to Mar 2024